Cargando…
New drugs in psychiatry: focus on new pharmacological targets
The approval of psychotropic drugs with novel mechanisms of action has been rare in recent years. To address this issue, further analysis of the pathophysiology of neuropsychiatric disorders is essential for identifying new pharmacological targets for psychotropic medications. In this report, we det...
Autores principales: | Caraci, Filippo, Leggio, Gian Marco, Salomone, Salvatore, Drago, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373420/ https://www.ncbi.nlm.nih.gov/pubmed/28408985 http://dx.doi.org/10.12688/f1000research.10233.1 |
Ejemplares similares
-
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin
por: Caraci, Filippo, et al.
Publicado: (2020) -
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2019) -
A New Human Blood–Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes
por: Fresta, Claudia G., et al.
Publicado: (2020) -
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D(3) Receptor Blockade
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2017) -
Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta
por: Zingales, Veronica, et al.
Publicado: (2021)